Many biopharmaceutical manufacturers are beginning to realize the importance of improving overall equipment effectiveness (OEE) to maximize the return on investment (ROI) of their assets, as well as improving productivity and reducing costs.
BioMarin, a developer of commercialized innovative biopharmaceuticals for rare, serious diseases and medical conditions, chose to partner with Infor to effectively implement a comprehensive enterprise asset management (EAM) solution that met the challenges and FDA compliance issues associated with a biopharmaceutical company.
In this on-demand webinar, experts will reveal the six cornerstones of a successful EAM program for maintenance and calibration. They will detail how BioMarin enhanced their Good Manufacturing Practice (GMP) compliance, developed new controlled business processes, and eliminated paper documentation of work. They now have a validated system that's helping them redefine their overall maintenance and reliability program.
View this on-demand webinar if you're interested in sharing best practices in maintenance and reliability for pharmaceuticals, biomed, and biopharmaceuticals.
Check the Infor EAM full event schedule.
Please complete the form below to access the recorded webcast.